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Live imagingThe visceral endoderm (VE) is an epithelial tissue in the early postimplantation mouse embryo that encapsu-
lates the pluripotent epiblast distally and the extraembryonic ectoderm proximally. In addition to facilitating
nutrient exchange before the establishment of a circulation, the VE is critical for patterning the epiblast. Since
VE is derived from the primitive endoderm (PrE) of the blastocyst, and PrE-derived eXtraembryonic ENdo-
derm (XEN) cells can be propagated in vitro, XEN cells should provide an important tool for identifying fac-
tors that direct VE differentiation. In this study, we demonstrated that BMP4 signaling induces the formation
of a polarized epithelium in XEN cells. This morphological transition was reversible, and was associated with
the acquisition of a molecular signature comparable to extraembryonic (ex) VE. Resembling exVE which will
form the endoderm of the visceral yolk sac, BMP4-treated XEN cells regulated hematopoiesis by stimulating
the expansion of primitive erythroid progenitors. We also observed that LIF exerted an antagonistic effect on
BMP4-induced XEN cell differentiation, thereby impacting the extrinsic conditions used for the isolation and
maintenance of XEN cells in an undifferentiated state. Taken together, our data suggest that XEN cells can be
differentiated towards an exVE identity upon BMP4 stimulation and therefore represent a valuable tool for
investigating PrE lineage differentiation.
© 2011 Elsevier Inc. All rights reserved.Introduction
The patterning of the early mouse embryo relies on reciprocal sig-
naling interactions between embryonic and extraembryonic tissues
(reviewed in (Arnold and Robertson, 2009; Rossant and Tam,
2009)). The two extraembryonic tissues, trophectoderm (TE) and
primitive endoderm (PrE), are speciﬁed and spatially segregated
away from the pluripotent epiblast (EPI) prior to embryo implanta-
tion into the maternal uterus (reviewed in (Cockburn and Rossant,rogram, Sloan-Kettering Insti-
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rights reserved.2010; Zernicka-Goetz et al., 2009)). TE is the ﬁrst extraembryonic lin-
eage established and forms an epithelial layer surrounding the inner
cell mass (ICM) of the blastocyst stage embryo. TE will form the tro-
phoblast giant cells and the extraembryonic ectoderm (ExE), essen-
tial for the establishment of a fetal–maternal connection. The PrE is
one of the two cell populations speciﬁed within the ICM, the other
being the EPI. PrE and EPI cells emerge initially in an apparent salt-
and-pepper fashion but, by the end of the preimplantation period,
are spatially segregated, with the PrE forming a single cell layer on
the surface of the ICM in contact with the blastocoel cavity (Chazaud
et al., 2006; Meilhac et al., 2009; Plusa et al., 2008). Thus, at the time
of blastocyst implantation, the pluripotent EPI is encapsulated by the
TE and the PrE (Fig. 1A).
After implantation, the PrE differentiates into the parietal endo-
derm (PE) and the visceral endoderm (VE). The PE, which lies adja-
cent to trophoblast giant cells, will form the endoderm of the
parietal yolk sac, while the majority of the VE will come to lie adja-
cent to extraembryonic mesoderm where it will form the visceral
yolk sac, the site of primitive hematopoiesis and vasculogenesis
(Fig. 1A). Cell transplantation experiments have revealed some
Fig. 1. BMP treatment alters XEN cell morphology. (A) Schematic representation of periimplantation (E4.5) and early postimplantation (E5.5 and E7.25) stage mouse embryos. High
magniﬁcation insets on the region where the exVE and extraembryonic mesoderm are apposed, representing the site of blood island formation (Ferkowicz and Yoder, 2005; Li et al.,
2005). Red, EPI and its derivatives; green, TE and TE derivatives; blue, PrE and PrE derivatives. (B) Diagramatic representation of the timeline of BMP treatment. (C) XEN cell mor-
phology after addition of BMP2 and BMP4 for 4 days at concentrations ranging from 5 to 20 ng/mL in serum culture conditions. (D) Kinetics of the morphological changes upon
addition of 10 ng/mL of BMP4 in serum and serum-free (N2B27) conditions. (C-D) High magniﬁcation zooms of low magniﬁcation images (inset) acquired with a 10× magniﬁca-
tion. In the insets, areas of epithelial cell colonies are highlighted in red.
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early postimplantation embryos (around embryonic day (E) 5.5 —
Fig. 1A) transplanted to recipient blastocysts were able to contribute
to both PE and VE (Gardner, 1982; Hogan and Tilly, 1981). Even so,
these cell types can be distinguished by their morphology and their
distinct biological properties. PE cells are characterized by their dis-
persed distribution and migratory behavior along the mural TE.
They secrete the extracellular matrix proteins that comprise Reich-
ert's membrane. By contrast, the VE forms an epithelial monolayer
that encapsulates the ExE proximally (where it is also referred as
exVE) and the EPI distally (where it is also referred to as emVE).
The VE is required for embryo survival and patterning. It functions
as the primary site of gas, nutrient and waste exchange prior to the
establishment of a circulation. As a polarized epithelium it possesses
the necessary intracellular machinery for directional absorption and
transport of compounds (reviewed in (Bielinska et al., 1999)). At
periimplantation stages, the VE plays a role in epiblast cell survival
as well as in the formation of the proamniotic cavity (Coucouvanis
and Martin, 1995, 1999). More recently, it has been shown that spe-
cialized regions within the VE are required for embryonic axis forma-
tion and epiblast patterning. For example at E5.5, a population of
molecularly and morphologically distinct emVE cells is evident at
the distal tip of the embryo (Rivera-Perez et al., 2003). Thispopulation, referred to as the distal VE (DVE), expresses transcription
factors such as Lhx1 and Hhex, and secretes antagonists of Wnt and
Nodal signaling including CER1, DKK1 and LEFTY1 (reviewed in
(Pﬁster et al., 2007)). Live imaging studies have revealed that DVE
cells actively and collectively migrate proximally within the plane of
the emVE epithelium towards the embryonic-extraembryonic junc-
tion (Migeotte et al., 2010; Srinivas et al., 2004), as they will converge
with a second population the anterior VE (AVE) (Takaoka et al., 2011;
Thomas and Beddington, 1996). This translocation of DVE/AVE cells
effectively converts the proximal-distal axis of the periimplantation
embryo into an anterior-posterior axis and results in the correct posi-
tioning of the primitive streak, deﬁning the posterior side of the em-
bryo concomitant with the start of gastrulation.
Gastrulation cell movements will give rise to the visceral yolk sac,
where exVE becomes apposed to extraembryonic mesoderm
(Fig. 1A). This is the site of speciﬁcation of hematopoietic and endo-
thelial progenitors, which are organized into blood islands (reviewed
in (Baron, 2005; Fraser and Baron, 2009; Medvinsky et al., 2011)). In-
structive signals emanating from exVE are essential in this process,
and exVE can reprogram anterior epiblast into posterior fates
(Belaoussoff et al., 1998). Candidate exVE secretory factors include
Vascular Endothelial Growth Factor (VEGF) and Indian Hedgehog
(IHH) (Dyer et al., 2001; Pierre et al., 2009).
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trate the dialog between embryonic and extraembryonic tissues has
been hampered by the limiting amounts and relative inaccessibility
of embryonic tissues. The isolation of stem cell lines derived from,
and representing, the three lineages of the blastocyst has offered an
attractive tool for investigating these events. At least three distinct
cell types of stem cells can be isolated from blastocyst stage mouse
embryos and propagated in culture, they include: EPI-derived embry-
onic stem (ES) cells (Evans and Kaufman, 1981; Martin, 1981), TE-
derived trophoblast stem (TS) cells (Tanaka et al., 1998) and PrE-
derived extraembryonic endoderm (XEN) cells (Kunath et al., 2005).
In terms of their molecular signature and cell morphology XEN
cells share many properties with the PrE as well as its PE and VE de-
rivatives, suggesting that they constitute a heterogenous population
when maintained in routine culture (Brown et al., 2010b; Kunath et
al., 2005). For example, the transcription factors GATA4, GATA6,
SALL4 and SOX17 and the receptor tyrosine kinase PDGFRα are re-
quired for the maintenance of XEN cells in vitro and are also required
in the PrE lineage in vivo (Artus et al., 2010, 2011; Lim et al., 2008;
Niakan et al., 2010). XEN cells express PE markers including Cytoker-
atin 19 (Krt19), Laminin B1 (Lamb1) and Sparc and t-type Plasminogen
activator (tPA). They also express VE markers including Hepatocyte
nuclear factor 4, (Hnf4a), Transthyretin (Ttr) and u-type Plasminogen
activator (uPA) (Brown et al., 2010b; Kunath et al., 2005). In chimeras,
XEN cells generally contribute preferentially to the PE (Kunath et al.,
2005). Live imaging has revealed morphological transitions indepen-
dent of cell division in XEN cell cultures, an indication that even if
XEN cells resemble PE cells some heterogeneity exists within the
cell population (Kunath et al., 2005). Most importantly, the extrinsic
signals required to maintain XEN cells in their undifferentiated
state, versus directing their differentiation into PE and VE lineages,
are currently not understood. Interestingly, Nodal stimulation in-
duced XEN cell to differentiate towards visceral endoderm and ante-
rior visceral endoderm fates (Kruithof-de Julio et al., 2011).
Given the role of BMP4 in VE differentiation in the embryo (Soares
et al., 2005, 2008; Yamamoto et al., 2009), we sought to test the effect
of this factor on XEN cells. We observed that upon BMP4 stimulation,
XEN cells underwent a dramatic change in their morphology and
formed a polarized epithelium. This morphological transformation
was accompanied by modulation of the expression of several regula-
tors of epithelium to mesenchyme (EMT) transition. The effect of
BMP4 was stable and reversible. Since BMP4-treated XEN cells could
be maintained in an epithelial state without further changes in their
morphology or gene expression, they likely had not entered into a
program of terminal differentiation. Strikingly, the effect of BMP4
on XEN cells was alleviated when LIF was added to the culture medi-
um, an observation that might shed light on the extrinsic conditions
necessary to isolate, maintain and manipulate XEN cells in culture.
To determine more precisely the identity of these cells, we charac-
terized their molecular signature by gene expression analysis. In ad-
dition to expressing epithelial markers, BMP4-treated XEN cells
upregulated markers highly expressed in the exVE, but not markers
speciﬁc to emVE or DVE, suggesting that BMP4 signaling directed
XEN cell differentiation towards an exVE-like identity. BMP4-
treated XEN cells expressed the VE-speciﬁc Afp::GFP transgene
(Kwon et al., 2006) but did so, surprisingly, in a mosaic manner. De-
tailed analysis revealed that this reporter was ﬂuctuating and that
these ﬂuctuations were associated with changes in the expression
of a limited number of genes. These observations therefore suggest
that BMP4-treated cells represent a relatively homogenous
population.
We were not able to formally validate the identity of BMP4-
treated XEN cells using chimera or teratoma experiments to probe
their developmental potential. However, as the exVE is adjacent to
the site of blood island formation in vivo, we assayed the ability of
BMP4-treated XEN cells to promote the expansion of primitiveerythroid cells (EryP) progenitors. We noted that even though both
untreated and BMP4-treated XEN cells promoted EryP progenitor ex-
pansion in vitro, BMP4-treated XEN cells exhibited a more potent ef-
fect, suggesting that these cells were functioning as exVE. In sum,
our observations suggest that XEN cells can be directed to differenti-
ate into various PrE derivatives and used as a cellular tool to investi-
gate inductive developmental processes, such as hematopoiesis (this
study) and cardiogenesis (Brown et al., 2010a).
Material and methods
XEN cell isolation and culture
The Afp::GFPTg/+ (Kwon et al., 2006) and Afp::GFPTg/+; CAG::
mRFP1Tg/+ (Long et al., 2005) XEN cell lines were established as pre-
viously described (Artus et al., 2010) onmitomycin C-treated primary
murine embryonic ﬁbroblasts (MEFs) in ES cell media containing re-
combinant leukemia inhibitory factor (LIF) (Mereau et al., 1993).
Wild-type (Brown et al., 2010b) and Afp::GFPTg/+ XEN cell lines
were routinely passaged every 2 to 3 days and maintained on
gelatin-coated dishes in high glucose Dulbecco's modiﬁed Eagle's
media (D-MEM, Gibco) supplemented with 0.1 mM 2-
mercaptoethanol, 1 mM non-essential amino acids, 1 mM sodium py-
ruvate, 2 mM glutamine, 100 units/mL penicillin and 100 μg/mL
streptomycin and 15% fetal bovine serum (FBS). All cells were
grown at 37 °C in 5% CO2. Stably expressing cell lines were generated
by co-transfection of CAG::GFP-GPI (Rhee et al., 2006) and PGK::Puro
(Tucker et al., 1996) plasmids. 10 days after selection in the presence
of 1.5 μg/mL puromycin, ﬂuorescent XEN cell colonies were picked
and expanded. IM8A1 XEN cells (kind gift of T. Kunath) were main-
tained exactly as described previously (Kunath et al., 2005).
For differentiation, XEN cells were cultured in the presence of re-
combinant BMP2, BMP4 or Noggin proteins (R&D systems) or LIF
(103 units/mL, ESGRO, Chemicon) at the indicated concentrations in
serum-containing conditions or in N2B27 medium. N2B27 media is
a 1:1 mixture of DMEM/F12 supplemented with N-2 and neurobasal
media supplemented with B-27 (all products from Gibco), as de-
scribed in (Ying and Smith, 2003). Inhibitor compounds used were:
2 μM Dorsomorphin (Sigma), 1 μM P6, 10 μM SB203580 (both from
Calbiochem), 20 μM LY294002 and 10 μM U0126 (both from Cell
Signaling).
Kidney capsule and blastocyst injection
Approximately 106 XEN cells were embedded in 0.2% agarose and
injected under kidney capsules of SCID mice (C.B-17 SCID, Taconic
Farms Inc.) as described in (Nagy et al., 2003). Tumors were collected
one to two months later, ﬁxed in formalin, embedded in parafﬁn wax
and sectioned. Sections were stained with Masson's trichrome stain.
5–10 Afp::GFPTg/+, CAG::mRFP1Tg/+ or CAG::GFP-GPI XEN cells were
injected into recipient ICR blastocysts and transferred to E2.5 pseudo-
pregnant ICR females as described in Nagy et al.(2003). Embryos were
dissected at E6.5 days and ﬂuorescently labeled cells were identiﬁed
using a laser scanning confocal microscope.
Immunostaining and DiI-HDL uptake assay
Cells were cultured on glass coverslips prior to immunostaining.
Coverslips were coated for 1 h at room temperature with 0.1% gelatin
(Sigma), Poly-L-lysine (Sigma) or 10 μg/mL Collagen type IV (BD Bio-
sciences), Laminin (BD Biosciences) or Fibronectin (Gibco). Immu-
nostaining was performed as previously described (Artus et al.,
2005, 2010). Primary antibodies used were: anti-AMN (1:500, kind
gift from E. Lacy), anti-βCAT (1:500, BD Transduction laboratories),
anti-CDH1 (1:300, Sigma), anti-CUBN (1:1000, kind gift from R.
Kozyraki), anti-CX43 (1:200, Sigma), anti-ITGA5 (1:100, Santa
248 J. Artus et al. / Developmental Biology 361 (2012) 245–262Cruz), anti-ITGA6 (1:100, Abcam), anti-LRP2 (1:5000, kind gift from
R. Kozyraki), anti-ZO-1 (1:200, Zymed). Alexa Fluor-conjugated sec-
ondary antibodies (Invitrogen) were used at 1:200. DNA was coun-
terstained with Hoechst 33342 (1:200, Invitrogen) and F-actin was
visualized with Alexa Fluor-phalloidin (1:1000, Invitrogen). Cover-
slips were mounted in Vectashield (Vector Laboratories).
For DiI-HDL uptake, XEN cells were cultured in XEN cell medium
supplemented with 10 μg/mL DiI-HDL (Biomedical Technologies
Inc.) for 2 h 30 min at 37 °C, then ﬁxed or washed twice in pre-
warmed media and cultured for an additional 30 min before ﬁxation.
Image data acquisition and processing
Wideﬁeld images were acquired using a Leica M165FC stereo-
dissecting microscope equipped with a Zeiss axiocam MRc camera.
Laser scanning confocal images of immunostained and GFP reporter
expressing cells were acquired on a Zeiss LSM 510 META. Fluores-
cence was excited with a 405-nm laser diode (Hoechst), a 488-nm
Argon laser (GFP, Alexa Fluor 488), a 543-nm HeNe laser (Alexa
Fluor 546, 568) and a 633-nm HeNe laser (Alexa Fluor 633 and
647). Images were acquired using a Plan-apochromat 20×/NA 0.75
objective, with z-stacks comprising an optical section thickness of
0.2–1.2 μm. Raw data were processed using Zeiss AIM software
(Carl Zeiss Microsystems) or IMARIS 6.4.2 software (Bitplane AG).
3D time-lapse data comprised z-stacks acquired at 10 min time
intervals.
Microarray analysis
Afp::GFPTg/+ XEN cells were cultured for 10 days in N2B27 medi-
um (control) or N2B27 medium supplemented with 25 ng/mL BMP4
before RNA extraction using TRIzol (Invitrogen). Afp::GFPTg/+ treated
XEN were routinely maintained in N2B27 supplemented with 10 ng/
mL BMP4. GFP-positive and -negative cells were sorted and cultured
for 24 h before RNA extraction. 200 ng of total RNA was labelled
using an Illumina® TotalPrep™ RNA Ampliﬁcation Kit (Applied Bio-
systems) and used to probe an Illumina expression array (Mou-
seWG-6_V2_0_R0_11278593) in triplicate for untreated and BMP-
treated conditions using Illumina BeadStudio version 3.4.0.
The raw Illumina data were analyzed using Bioconductor packages
in R statistical language. Data were ﬁrst normalized using LumiEx-
presso ( ) function. The differentially expressed genes in each pair-
wise comparison were obtained using the Limma ( ) R-package
(with FDR=0.05 and fold change cut-off 2). Functional categories
were identiﬁed using the DAVID tool (http://david.abcc.ncifcrf.gov/)
and illumina probes were mapped to gene symbols names using
lumiMouseIDMapping.db. Functional categories with Benjamini-
corrected enrichment p-values ≤0.05 were declared enriched. Data
have been deposited in NCBI GEO database under the accession num-
ber GSE32094 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE32094).
Real-time quantitative PCR
Total RNA was reverse transcribed using the Superscript III First-
Strand Synthesis Kit (Invitrogen) and 50 ng of the product used as tem-
plate for PCR ampliﬁcation. Quantitative real-time reverse transcription-
polymerase chain reaction (q-PCR) was performed in triplicate using
SYBR Green (Roche) on a LightCycler 480 real-time PCR instrument and
analyzed with LightCycler 480 software (version 1.5.0.39). Primer se-
quences used are described in Samavarchi-Tehrani et al.(2010).
Primitive erythroid colony formation
ε-globin::H2B-EGFPTg/+ (Isern et al., 2008) embryos were dissected
at E8.0–8.5 (2–12 somite pairs). Whole embryos were dispersed intosingle cells using 0.05% trypsin/0.53 mM EDTA (Cellgro, 25-052-CI),
and EryP (GFP+) cells were sorted on an BD Inﬂux™ Cell Sorter or
DAKO-Cytomation MoFlo High Speed Sorter. 104 EryP cells were cul-
tured on gelatin-coated 24-well plates containing XEN cells, BMP4-
induced XEN cells or without XEN cells in Iscove's Modiﬁed Dulbec-
co's Media (IMDM; Gibco, 12440) supplemented with 10% fetal bo-
vine plasma derived serum (PDS; Animal Technologies, FBP-186),
5% protein-free hybridoma medium (PHMII; Invitrogen,
12040–077), 2 mM L-glutamine, 25 μg/mL ascorbic acid, 0.6 mM 1-
Thioglycerol (MTG; Sigma, M6145) and 4 U/mL human recombinant
erythropoietin (EPO; Epogen). XEN cells were plated 1–4 days prior
to co-culture with EryP and they were always >90% conﬂuent at
the time of EryP co-culture. After 5 or 10 h, non-adherent cells were
collected and mixed with EryP-CFC medium (40% Methylcellulose
Methocult M3134 (Stemcell Technologies, 03134), 10% PDS, 5%
PFHMII, 2 mM L-glutamine, 25 μg/mL ascorbic acid, 0.6 mM MTG
and 4 U/mL human EPO in IMDM) and incubated at 37 °C in 5% CO2
as previously described (Isern et al., 2011). Primitive erythroid colo-
nies were scored 4–5 days later. Of note, we found that culturing
EryP for as long as 24 h resulted in reduced cell viability and progen-
itor activity (JI, S. Fraser, Z. He, PD and MHB data not shown).Results and discussion
BMP4 signaling stably and reversibly alters XEN cell morphology
XEN cells are stem cells derived from and representative of the PrE
lineage (Kunath et al., 2005). Given the role of BMP signaling in the
formation and differentiation of the visceral endoderm within the
PrE cell lineage of the mouse embryo (Fig. 1A), we sought to deter-
mine the consequences of activating this signaling pathway in XEN
cells. To do so, we ﬁrst tested the effect of adding recombinant BMP
proteins at various concentrations ranging from 5 to 20 ng/mL in
serum containing culture conditions for 4 consecutive days (Fig. 1B).
As previously reported (Kunath et al., 2005), when maintained
under standard culture conditions at low densities, XEN cells resem-
ble PE cells and exhibit at least two distinct morphologies that are
readily identiﬁed with brightﬁeld illumination: a round refringent-
type morphology and a more adherent-type morphology. At higher
densities these two cell types coexisted but were more difﬁcult to dis-
tinguish (Fig. 1C). We noted that exposure of XEN cells to BMP4 or
BMP2 produced a profound effect, such that after 4 days of treatment,
cells acquired a homogenous morphology. They appeared ﬂattened
and formed tight monolayer colonies that usually covered 50 to 80%
of the surface of the cell culture dish (Fig. 1C, insets). This morpholo-
gy was rarely observed in XEN cells maintained under standard cul-
ture conditions. We noted that BMP2 and BMP4 had a similar effect
on cell morphology. Interestingly, Bmp2 and Bmp4 expression has
previously been reported in XEN cells (Brown et al., 2010b; Kunath
et al., 2005). Our observations suggest the existence of a threshold
of BMP activity that, when exceeded, leads to the observed morpho-
logical transition.
A similar effect was observed using several independently derived
XEN cell lines including IM8A1, a cell line isolated under TS cell deri-
vation conditions and maintained in TS cell media without heparin
and FGF4 (Kunath et al., 2005) (Fig. S1A). We also noticed that the ef-
fect was more pronunced when BMP4 was apply to serum containing
medium (RPMI1640) compared to ﬁbroblast conditioned medium
(MEF-CM). This suggests that components secreted from ﬁbroblasts
inhibit the effect of BMP stimulation. Of note, although addition of re-
combinant Noggin protein (100 ng/mL) or Dorsomorphin (2 μM)
inhibited the effect on XEN cells resulting from the addition of
10 ng/mL BMP4, neither elicited an overall effect of BMP inhibition
on untreated XEN cells as evident by cell morphology, cell prolifera-
tion and cell death (Fig. S2). These data would suggest that BMP
Fig. 2. Removal of BMP4 leads to a reversion of the morphological transition. (A) Dia-
gramatic representation of BMP withdrawal scheme. (B) Kinetics of the morphological
changes induced upon BMP4 removal (lower panels) compared to XEN cells main-
tained in serum-free (N2B27) medium supplemented with 10 ng/mL BMP4 (upper
panels). High magniﬁcation zooms of low magniﬁcation images (inset) acquired with
a 10× magniﬁcation. In the insets, areas of epithelial cell colonies are highlighted in
red.
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respond to BMP stimulation.
We next analyzed the kinetics of the observedmorphological tran-
sition resulting from addition of BMP proteins to XEN cell cultures.
XEN cells were treated with 10 ng/mL BMP4 in both serum conditions
and serum-free conditions (N2B27 medium) and their morphology
was monitored daily (Fig. 1D). During the ﬁrst 2–3 days after BMP4
addition, both untreated and treated XEN cells exhibited their usual
dispersedmorphology. However, after 3 days, a few ﬂattened colonies
were observed in cells maintained in the presence of BMP4. The size of
these colonies greatly increased by 4 days. This rapid morphological
conversion between day 3 and day 4 suggests that almost all XEN
cells are able to undergo this transition, rather than a subset of the
population which then exhibit a selective growth advantage. Notably,
we did not observe any increase in cell death during BMP4 stimulation
that could account for a selective elimination of a subset of cells. We
also noticed that when treated cells were trypsinized and replated in
presence of BMP4, they would retain this morphology at high density
(data not shown). This would suggest that this morphological change
was dependent on cell density and could account for the change in
morphology between day 3 and day 4 which corresponds to the
time when cells reached conﬂuency.
This morphological change was observed both in cells maintained
in serum containing conditions on tissue culture treated dishes or on
glass coverslips coated with gelatin. In serum-free N2B27 media, we
noted that, in contrast to untreated XEN, BMP-treated cells were
more difﬁcult to grow on glass or gelatin-coated glass, as they failed
to properly attach (Fig. S3). We tested different extracellular matrix
(ECM) substrates including poly-L-lysine, and found that coating cov-
erglass with collagen type IV, laminin or ﬁbronectin supported the at-
tachment and subsequent growth of both treated and untreated cells
(Fig. S3). These data suggest that ECM components can affect XEN cell
behavior, growth and differentiation, as also suggested by our micro-
array analyses (Fig. S4).
Interestingly, we found that BMP4-treated XEN cells could be
maintained for extended periods of time (more than ten passages)
without any signiﬁcant loss of viability or change in their morphology.
Moreover, these cells could be efﬁciently recovered in this state upon
cryopreservation and subsequent thawing. Thus, despite the profound
change in cell morphology, BMP signaling might not promote entry
into a full program of cellular differentiation often associated with
cell cycle exit. This is for example the case with ES cells, which can
be maintained virtually indeﬁnitely in an undifferentiated state, how-
ever their differentiation is usually irreversible and accompanied by
cell death (Duval et al., 2000) and cell cycle exit (Burdon et al., 2002).
Next, we tested whether sustained BMP4 signaling was required
to maintain this phenotype. To do so, we removed BMP4 from the cul-
ture medium and monitored cell behavior daily (Fig. 2A). BMP4-
treated XEN cells maintained a ﬂattened adhesive morphology over
a period of 4 days (Fig. 2B, upper panel). By contrast, 2 days after
BMP4 removal, some cells started to detach and migrate away from
colonies, and by 4 days most of the cells within a culture were no lon-
ger associated in colonies (Fig. 2B, lower panel). This loss of epithelial
integrity was not accompanied by an overall increase in cell death
(data not shown). These data therefore suggest that the effect of
BMP stimulation is reversible, and that maintenance and expansion
of the XEN cells exhibiting a ﬂattened epithelial-like morphology re-
quires the presence of BMP4 or BMP2 in the culture media.
Taken together, our data suggest that BMP2/4 signaling regulates
XEN cell morphology by inducing the coordinate formation of adher-
ent ﬂattened cells. In serum-free culture conditions this effect is pro-
moted by the presence of ECM such as ﬁbronectin. Sustained
signaling is required to maintain cells in this state. Moreover, this
morphological transition is reversible and apparently stable, as XEN
cells can be maintained in this state for extended periods of time be-
fore reverting in the absence of BMP4 protein.BMP4 signaling induces the formation of a polarized epithelium in XEN
cells
Since the morphology adopted by BMP4-treated XEN cells was
reminiscent of epithelia, we sought to clarify the nature of this mor-
phological transition. To do so, we analyzed the localization of various
proteins exhibiting a polarized distribution in epithelial cells and in-
volved in cell-cell junctions and communication. These included
adherens junction components such as βcatenin (βCAT) and E-
cadherin (CDH1), Zona occludens-1 (ZO-1), which localizes to tight-
junctions, and the gap junction protein Connexin-43 (CX43)
(Figs. 3A and Fig. S1B). Immunodetection of these proteins revealed
that, in contrast to control XEN cells that established relatively poor
connections with their neighbors, even at high densities, treatment
with BMP4 induced a morphological transformation of XEN cells
and concomitant localization of these proteins at cell-cell contacts.
These data indicate the establishment of adherens, tight and gap
junctions in BMP4-treated XEN cells and suggest these cells have
transformed into an epithelium.
Gene expression analyses, carried out by expression proﬁling cells
using microarrays, revealed that in addition to the establishment of
cell-cell junctions, BMP4-treated XEN cells had modulated the ex-
pression of various genes encoding structural proteins (Fig. S4). We
observed an upregulation of the intermediate ﬁlament proteins Cyto-
keratin 18 (Krt1-18), Cytokeratin 19 (Krt1-19) and downregulation of
Cytokeratin 23 (Krt1-23). Interestingly, several genes encoding lami-
nin subunits were downregulated (e.g. Lama1, Lamb1-1 and Lamc1),
and the expression levels of Nidogen 1 (Nid1) and Vitrin (Vit) were re-
duced. Thus, several major components of Reichert's membrane syn-
thesized by PE cells were downregulated upon BMP4 treatment
(Oner et al., 2006).
In addition, we observed a change in the signature of expression of
various integrins, suggesting that BMP4 treated XEN cells might mod-
ify their afﬁnity for ECM proteins. For example, comparisons between
our expression proﬁle analysis with the KEGG pathway ‘ECM-recep-
tor interaction’ (http://www.genome.jp/kegg-bin/show_pathway?
hsa04512) revealed that ﬁbronectin receptors (ITGA5-ITGB1
and ITGAV-ITGB6) were enriched, whereas ITGA6-ITGB1 (laminin
Fig. 3. BMP4 stimulation induces the formation of a polarized epithelium. (A) Visualization of adherens junction (βCAT, CDH1), tight junction (ZO-1) and gap junction (CX43) con-
stituent proteins in control and BMP4-treated XEN cells. BMP4 treatment also affected the localization and expression of Integrin α5 (ITGA5) and Integrin α6 (ITGA6) proteins.
(B) Changes in the localization of F-actin, Amnionless (AMN), Cubilin (CUBN) and LRP2 proteins upon BMP4 treatment. Images correspond to single optical sections and orthogonal
views (below), insets are 3D projections. (C) DiI-HDL uptake of control and BMP-4 treated XEN cells incubated for 2 h 30 min in presence (PULSE) and then for 30 min in absence
(CHASE) of the dye. Arrowheads indicate cells with low levels of DiI-HDL. (D) qPCR analysis of MET transcriptional regulator gene expression in control (−) and BMP4-treated XEN
cells. (A–C) βCAT, CDH1, ZO-1, CUBN, LRP2, Di-HDL, red; F-actin, AMN, green; nuclei counterstained with Hoechst, blue. Scale bars: 20 μm.
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lated (Figs. 3A and Fig. S4).
In vivo, the PrE of the blastocyst and VE of the postimplantation
embryo, but not the PE, form an epithelium that exhibits apical-
basal polarity. A ﬁrst indication that BMP4-treated XEN cells had ac-
quired apical-basal polarity came from the distribution of F-actin,
which was homogenously distributed in control XEN cells, but
which was localized at the apical cortex of BMP4-treated cells
(Fig. 3B). During embryonic development, a complex of membrane-
associated proteins comprising Amnionless (AMN), Cubilin (CUBN)
and Megalin (LRP2) is localized to the apical surface of VE cells,
where it mediates endocytosis critical for embryogenesis (Kalantry
et al., 2001; Smith et al., 2006; Strope et al., 2004; Tomihara-
Newberger et al., 1998). We noted that BMP4 treatment increased
the level of expression of both Amn (array fold change (FC)=
+16.5) and Lrp2 (array FC=+3.7) in XEN cells. To further investi-
gate the establishment of epithelial polarity in these cells, we ana-
lyzed the localization and noted any changes in the subcellular
distribution of this complex. AMN was not detected in untreatedcells, whereas CUBN and LRP2 were expressed in a subset of cells
where they exhibited a homogenous localization at the cell surface
(Fig. 3B). BMP4 stimulation induced a global increase in the level of
AMN/CUBN/LRP2 complex proteins, which were found to be apically
localized, consistent with the notion that a polarized epithelium re-
sembling VE had formed upon BMP treatment.
It has previously been reported that the AMN/CUBN/LRP2 com-
plex mediates HDL uptake in the VE, intestine and kidney (Hammad
et al., 1999; Kozyraki et al., 1999). Uptake can be visualized using a
ﬂuorescent DiI-HDL probe (Hatzopoulos et al., 1998; Smith et al.,
2006). The status of HDL uptake by PrE cells of the blastocyst or PE
is not known. We therefore sought to determine if BMP4 treated
XEN cells were endocytosing HDL via the apically-localized CUBN
complex. Cells were incubated in the presence of the ﬂuorescent
DiI-HDL dye, washed and immediately ﬁxed or chased for 30 min.
Surprisingly, we found that virtually all untreated XEN cells were la-
beled, whereas BMP-treated cells exhibited lower levels of DiI-HDL
incorporation, with approximately half of them not having incorpo-
rated the dye (Fig. 3C, arrowhead). We therefore conclude that
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endocytosis in comparison to untreated XEN cells. This observation
is interesting as untreated cells, which do not express Amn, more
readily take up DiI-HDL as compared to treated cells which express
all three components of this complex.
This situation apparently contrasts with the endoderm of the vis-
ceral yolk sac which has a high propensity for DiI-HDL uptake
(Hatzopoulos et al., 1998; Smith et al., 2006). Several explanations
could account for this disparity. First, the activity of the CUBN com-
plex may be modulated by post-translational modiﬁcations that differ
in vivo and in cells grown in culture. Second, the difference of cell
morphology between rounded untreated XEN cells and epithelial
BMP4-treated XEN cells may affect the total cell membrane surface
that can uptake the DiI-HDL. Lastly, additional HDL binding proteins
may be differentially expressed between treated and untreated XEN
cells. This is for example the case of Scarb2, an alternative splicing
variant of SR-BI, encoding the scavenger protein SR-BII (Eckhardt et
al., 2004) which we found to be downregulated by a 2.5-fold change.
We next sought to determine whether this dramatic epithelializa-
tion concomitant with BMP4 addition to the culture media was driven
by a mesenchymal-to-epithelial transition (MET) mechanism. A
major effector of MET is E-cadherin, which we found to be upregu-
lated in BMP4-treated XEN cells as assayed by immunoﬂuorescence
(Fig. 3A), microarray (FC=+1.96) and qPCR (FC=+1.86; Fig. 3D).
E-cadherin expression is tightly and directly controlled by the action
of multiple negative mesenchymal transcriptional regulators, such as
SLUG, SNAIL, ZEB1 and ZEB2 (Thiery et al., 2009). We therefore ana-
lyzed the expression of these negative transcriptional regulators by
global gene expression and qPCR (Fig. 3D and Table 2). We did not
ﬁnd evidence for differential expression of Slug (array FC~1, qPCR
FC=−1.2). Snail was modestly upregulated in our arrays (array
FC=+1.3 and +1.5) but downregulated by qPCR (qPCR FC=
−4.1). This discrepancy could be explained by the speciﬁcity of the
microarray probesets. Similarly, Zeb2 (Zfhx1b) was not found to be
differentially expressed in our microarray (array FC~1), but was
downregulated by qPCR (qPCR FC=−2.3). The most signiﬁcantly dif-
ferentially expressed gene was Zeb1 (Zfhx1a), which we found down-
regulated both in our microarray (FC=−3.1) and by qPCR (FC=
−16.1), suggesting that ZEB1 is likely to be a key regulator of E-
cadherin in XEN cells and also perhaps in vivo within the VE.
Epithelium tomesenchyme transition plays important roles during
embryogenesis and in cancer progression andmetastasis (reviewed in
(Ferrer-Vaquer et al., 2010; Moustakas and Heldin, 2007; Nowotschin
and Hadjantonakis, 2010; Thiery et al., 2009)). Contrasting with its ef-
fect on XEN cell differentiation, BMP signaling has been associated
with various EMT transitions where its role is relatively well docu-
mented in neural crest formation and delamination (Trainor et al.,
2003), atrioventricular valvulogenesis (Inai et al., 2008) and in metas-
tasis and cancer progression (Bailey et al., 2007). However, BMP4 has
also been identiﬁed as a key mediator of MET during somatic cell
reprogramming (Samavarchi-Tehrani et al., 2010) and BMP7 has
been implicated in MET in melanoma cells (Na et al., 2009) and
adult renal ﬁbroblasts (Zeisberg et al., 2005). This indicates that the ef-
fect of BMP signaling on cell morphology is largely context dependent.
Collectively, our data demonstrate that BMP4 signaling induces a
mesenchymal-to-epithelial transition (MET) in XEN cells. This epithe-
lium is polarized and shares some common characteristics with the
exVE, as well as the mature PrE layer of the late blastocyst, which
also expresses Amn, Cubn and Lrp2 (Gerbe et al., 2008).
The effect of BMP4 is antagonized by LIF signaling
Mouse ES cells can be maintained undifferentiated in deﬁned
media supplemented with LIF and BMP4 (Ying et al., 2003). In this
scenario, LIF and BMP4 signaling cooperate to suppress ES cell exit
from pluripotency and lineage commitment. We therefore sought todetermine if this might be also the case for XEN cells. Having deter-
mined that BMP4 treatment induces a morphological change within
4 days, we repeated this experiment in presence of LIF at a concentra-
tion used in standard ES cell cultures (103 units/mL) (Fig. 4A). Strik-
ingly, there was no change in XEN cell morphology when cells were
cultured in the presence of BMP4 and LIF, suggesting that LIF antago-
nizes the effect of BMP4 treatment on XEN cells.
LIF activates its LIFR/GP130 heterodimeric receptor and several
secondary signal transducers including MAPK, PI3K and JAK/STAT
(Fig. 4B). To determine which of these pathway branches might be
transducing the LIF antagonizing signal, we pre-treated control and
BMP4-treated cells with various pharmacological compounds inhibit-
ing these secondary transducers for 6 h, then added LIF protein and
subsequently cultured the cells for 3 additional days in the presence
of LIF and inhibitors (Fig. 4C). We noted that inhibition of p38
(SB203580), PI3K (LY294002) and P6 (JAK/STAT) affected XEN cell
morphology, but none of these inhibitors were found to induce MET
transition. When BMP4-treated cells were cultured in the presence
of LIF, epithelial cell morphology was lost and XEN cells reverted to
their original morphology. This effect was even more pronounced
when cells were treated with MEK or PI3K inhibitors. Strikingly, inhi-
bition of p38 or JAK/STAT pathways attenuated the LIF effect such that
various areas maintained an epithelial morphology (Fig. 4C).
Collectively our data demonstrate that LIF antagonizes the mor-
phological transition induced by BMP, likely through the P38 and
JAK/STAT downstream signal transducers. These observations might
provide some insight into the extrinsic conditions required for XEN
cell isolation and maintenance. Indeed, XEN cell lines have been iso-
lated using both protocols for ES cellas well as TS cell derivation
(Kunath et al., 2005). Interestingly, these protocols have at least one
factor in common, this being LIF. LIF is secreted by embryonic ﬁbro-
blast feeder cells, and so is present in the ﬁbroblast-conditioned me-
dium used in some TS cell protocols, while exogenous LIF is also
added to ES cell medium. This may also explain why we observed
an attenuated effect consecutive to BMP4 stimulation when cells
were cultured in presence of ﬁbroblast conditioned medium com-
pared to serum containing medium (Fig. S1A). In addition, Lif, LifR
and Gp130 transcripts were detected in our microarray analysis. It is
therefore possible that LIF acts as a paracrine signal that promotes
XEN cell maintenance. Future studies will be required to address the
role of LIF signaling in XEN cell biology.
BMP4-treated XEN cells acquire an exVE-like identity
Epithelium formation and localization of AMN/CUBN/LRP2 com-
plex was an indication that BMP-treated XEN cells had acquired a
VE-like identity and did not resemble PE, which are dispersed migra-
tory cells. To gain further insight into the identity of the BMP-treated
cells, we analyzed their global gene expression by microarray analysis
using Illumina MouseWG-6 beadchip technology (Fig. 5A). Out of
45,279 probesets, 20,178 probesets were detected in our assay. Pair-
wise comparisons between untreated and BMP4-treated XEN cells
with a fold change cut-off of 2 and a false discovery ratio (FDR) of
0.05 identiﬁed 195 upregulated genes and 305 downregulated
genes in the BMP4-treated population (Fig. 5 and Tables 1, 2). Gene
ontology analyses of the differentially expressed genes revealed an
enrichment of genes assigned to “extracellular” and “basement mem-
brane” categories, supporting the idea that BMP4-treated cells had
adopted VE epithelial characteristics (Fig. 5B).
Interestingly, we found that BMP4-treated cells upregulated a sig-
niﬁcant number of genes whose expression is speciﬁc to the VE, and
to exVE in particular (Fig. 5D and Tables 1 and 2). These included
Amn (Kalantry et al., 2001; Strope et al., 2004; Tomihara-Newberger
et al., 1998), Spink3, Lgals2, Tdh, (Hou et al., 2007), Habp2 (Hou
et al., 2007), Cited1 (Dunwoodie et al., 1998), Claudin6 (Anderson
et al., 2008), Dpp4, Foxa3, Rab15 (Sherwood et al., 2007), as well as
Fig. 4. LIF signaling antagonizes the effect of BMP4. (A) Effect of BMP4 treatment on XEN cell morphology in absence (control) or in presence (LIF) of LIF. XEN cells were cultured for
4 days in serum conditions supplemented with 5 to 10 ng/mL BMP4 and 103 units/mL LIF. (B) Schematic representation of signal transduction pathways activated upon LIF ligand
binding to LIFR/GP130 receptor and inhibitors used to block their activities. (C) Inhibition of P38 and JAK/STAT attenuates the inhibitory effect of LIF signaling on BMP driven MET.
(A, C) Zoom magniﬁed pictures of low magniﬁcation acquisitions (inset) acquired with a 10× zoom. In the insets, epithelial cell colonies were highlighted in red.
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et al., 1991) and several genes encoding apolipoprotein family mem-
bers including Apoa1, Apoa2, Apoe and Apom. In addition, we observed
that the panVE-speciﬁc Afp::GFP transgenic reporter (Kwon et al.,
2006) was expressed in BMP4-treated but not in untreated XEN
cells (Fig. 6A).
We next used ﬂow cytometry to analyze the percentage of Afp::
GFP positive cells after 4 days of culture in serum or serum-free con-
ditions in the presence of increasing concentrations of BMP2 or
BMP4 (Fig. 6B). We observed that a maximum induction of Afp::GFP
reporter expression was reached between 25 ng/mL and 50 ng/mL
BMP4. Interestingly, we noticed an improved induction under
serum-free as compared to serum-containing conditions. Similarly,
addition of BMP2 also induced reporter expression and optimal in-
duction was observed at a concentration of 50 ng/mL. Taken together,
both BMP2 and BMP4 have the ability to induce Afp reporter suggest-
ing that they may exert similar effects on XEN cell differentiation.
Importantly, with the exception of Hhex (1.9-fold-change upregu-
lation), the array data did not reveal a signiﬁcant increase in the ex-
pression of DVE/AVE markers including Cer1, Dkk1, Lefty1 and Lhx1.
We therefore conclude that BMP4 activity preferentially affects the
expression of exVE genes. Notably, we did not observe any differen-
tial change in the expression levels of several transcription factors
proposed to comprise a PrE ‘stem’ core regulatory network such as
Gata4, Gata6, Sox7, Sox17 and Sall4 (Lim et al., 2008; Niakan et al.,
2010). Taken together, our gene expression data suggested that
BMP4 stimulation directs XEN cell differentiation towards exVE-like
identity.
Surprisingly, no major defect in PrE lineage differentiation has
been reported from the genetic inactivation of various BMP ligand-
encoding genes. For example, Bmp2-deﬁcient embryos exhibit defectsin amnion/chorion formation and heart development (Zhang and
Bradley, 1996). Bmp4 inactivation results in impaired mesoderm for-
mation at the time of gastrulation (Lawson et al., 1999; Winnier et al.,
1995) and downregulation of Bmp4 has been reported to affect AVE
formation (Soares et al., 2005, 2008). Furthermore, Bmpr2 mutants
fail to properly specify the DVE (Yamamoto et al., 2009). Though it
cannot be ruled out that the VE layer of these mutants may exhibit
further uncharacterized defects, some degree of functional redundan-
cy may exist between co-expressed BMP ligands that could account
for the absence of a phenotype in PrE maturation. Using XEN cells
as an ex vivo model of PrE lineage maturation, we provide evidence
suggesting that BMP signaling promotes differentiation towards an
exVE fate.
Fluctuation of the Afp::GFP reporter in BMP4-treated XEN cells
Having demonstrated that the Afp::GFP transgene reporter was ac-
tivated upon BMP4 treatment of XEN cells, we sought to further in-
vestigate the observed heterogeneity in transgene expression. We
noted that approximately half (40–50%) the population of BMP-
treated XEN cells were GFP-positive at any one time, and that GFP-
positive and GFP-negative cells were intermixed within the culture
dish (Fig. 6A). These observations could be explained by a non-
uniform ability of XEN cells to respond to BMP signaling, perhaps
reﬂecting the inherent heterogeneity of XEN cell cultures. Alterna-
tively, the expression of the transgene could ﬂuctuate within a single
cell and observations made at single time-points would reveal the co-
existence of GFP-positive and GFP-negative cells. To distinguish be-
tween these two scenarios, we ﬂow sorted GFP-positive and GFP-
negative cells and monitored the activity of the Afp::GFP reporter for
3 days post-sorting, when cells were maintained in the presence of
Fig. 5.Microarray data analysis. (A) Diagramatic representation of the experimental scheme used for global gene expression analysis. Cells were treated for 10 days in presence of
25 ng/mL BMP4, a concentration optimal for the induction of the Afp::GFP transgene. (B) Functional gene ontology analysis of the differentially expressed genes using the DAVID
tool with a p-value ≤10−3. Top 50 genes downregulated (C) and upregulated (D) upon BMP4 treatment with their associated fold changes.
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pearance of GFP-positive cells after 2 days in culture and, by 3 days,
40% of the cells were expressing the reporter. Conversely, GFP-
negative cells were identiﬁed 3 days post sorting the GFP-positive
cells. Together, these data suggest that Afp::GFP reporter expression
was ﬂuctuating within BMP-treated XEN cells.To further validate these observations, we live imaged BMP-
treated XEN cells over a 13-hour time period (Fig. 6F and Movie 1).
Several cells within the frame of view were seen to upregulate the
Afp::GFP reporter (Fig. 6F, dashed red lines depict cell perimeters).
However, we did not readily detect cells exhibiting a signiﬁcant de-
crease in levels of GFP ﬂuorescence. Since we previously noted that
Table 1
List of the genes upregulated (FC≥2, FDR=0.05) in XEN cells upon BMP4 treatment.
Illumina ID Gene symbol Fold change
1070452 Tnnc1 26.2
2510743 Amn 16.5
3830114 Flt1 14.5
7610097 Spink3 11.8
3890500 Gpc3 10.8
3990292 Cited1 9.3
3370136 Gpc3 9.1
2690070 Fbln1 9.1
6450193 Lgals2 8.6
4850253 BC049730 7.7
5260364 4933402E13Rik 7.6
1660445 scl0002507.1_236 7.3
1440543 H19 7.2
5860243 Plac8 6.9
4490020 Cldn6 6.5
7210687 Apoe 6.5
2340300 Ddc 6.3
5050653 Igf2 6.1
5050468 2210011C24Rik 6.0
780348 Grb7 6.0
4640446 Fmo1 5.9
3290056 H19 5.9
7160204 Serpina10 5.8
2070692 Akr1c19 5.6
1570594 Socs3 5.6
6200692 Idb1 5.6
610601 Ddc 5.4
1690164 Fbln1 5.4
5360181 Cpm 5.1
5290376 Foxa3 5.0
4010019 Iﬁtm1 4.9
1740114 Spint1 4.6
4760040 Habp2 4.2
4390553 6330505N24Rik 4.2
7330278 Lgals1 4.1
6350537 Apoa2 4.1
4570451 Cdkn1c 3.9
4590025 Habp2 3.9
3060546 Dpp4 3.9
2320403 Gch1 3.7
6270296 Slc9a3r1 3.7
5690367 Lrp2 3.7
5670722 Hspb1 3.6
3990397 Nipsnap1 3.6
4150682 0610009F02Rik 3.5
5870220 Car14 3.5
10364 Dp1l1 3.5
10768 Gm2a 3.5
3130739 4933402E13Rik 3.4
670500 Fignl1 3.4
6590343 Rab15 3.3
7100577 Axl 3.2
2680431 Rnf130 3.1
3890332 Gadd45a 3.1
4040270 Agrn 3.1
2470086 Slc39a4 3.1
6370020 scl0001849.1_2273 3.1
4290678 Snx15 2.9
580609 Gadd45a 2.8
3610025 BC004728 2.7
5720239 Inpp5f 2.7
4490554 Sema4a 2.7
5960577 Iﬁtm1 2.7
4220554 Dsg2 2.7
270341 Emb 2.7
4290709 Iﬁ30 2.7
6350044 Slc2a1 2.7
1710747 Nr6a1 2.7
4250280 9130210N20Rik 2.6
650711 Dgat2 2.6
6250180 Cyp2s1 2.6
70221 Mtap7 2.6
6520356 Igf2bp3 2.6
5490301 Tnk1 2.6
6290411 Pank1 2.6
Table 1 (continued)
Illumina ID Gene symbol Fold change
270592 Plekha2 2.6
4880386 Ly64 2.5
110717 AI428936 2.5
5810538 2610001E17Rik 2.5
780360 Car14 2.5
4610474 Prrg2 2.5
2650601 Prss8 2.5
1990551 Cyp26a1 2.5
6620328 AW548124 2.5
1030170 Map3k1 2.5
7200240 Sap30 2.5
6450347 B4galnt2 2.5
4730367 Iﬁ30 2.5
2340131 Igf2bp3 2.4
1170228 Tdh 2.4
1770707 Sephs2 2.4
4010133 Cdc42ep4 2.4
3360053 Pcsk9 2.4
3940687 Myo6 2.4
4880193 Abcc4 2.4
4880433 Upk1b 2.4
6480433 H2afy 2.4
5810414 Cxadr 2.4
730753 Map3k1 2.4
3840446 Mlp 2.4
1170706 Krt1-19 2.4
2760750 Mreg 2.3
4040750 Edg2 2.3
2470437 Hnf4a 2.3
4150427 1110002D22Rik 2.3
1110452 2510049J12Rik 2.3
2510369 Elf3 2.3
5290333 Me2 2.3
3290402 Pgc 2.3
4220326 Mcm10 2.3
2760187 Apom 2.3
6040066 Cdx2 2.3
1190026 5530401J07Rik 2.3
1990037 Dhx32 2.3
110471 Idb3 2.3
3460703 Hdac6 2.3
460327 Slc2a3 2.3
50168 3110043J09Rik 2.3
2320129 A930017N06Rik 2.3
70630 Pgd 2.3
110400 LOC382127 2.2
940646 9130210N20Rik 2.2
2510204 Apoa1 2.2
3400209 Stx3 2.2
610743 Nasp 2.2
10575 Cideb 2.2
240653 G6pdx 2.2
2970273 1200014P03Rik 2.2
7510070 Nme4 2.2
3060470 Peg10 2.2
7040133 Avpi1 2.2
2340167 Rad52b 2.2
4900288 A630098G22Rik 2.2
2970647 2610206G21Rik 2.2
2690368 BC004728 2.2
3180068 Akr7a5 2.2
5340402 Loxl2 2.2
5900274 Gyltl1b 2.2
7380037 Mlp 2.1
6580129 Hook2 2.1
1050170 Cdca3 2.1
4540612 Igsf4a 2.1
5340072 Mdk 2.1
2320541 Car12 2.1
10402 Trim25 2.1
6020181 Abat 2.1
4540603 9630055N22Rik 2.1
70341 Txnip 2.1
160332 Timp1 2.1
3780082 Edg2 2.1
1710377 scl0002449.1_77 2.1
4640215 Timp1 2.1
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Table 1 (continued)
Illumina ID Gene symbol Fold change
1400309 Timp3 2.1
2490091 Bbx 2.1
3390273 Ndc80 2.1
7320338 Pitx2 2.1
1980138 Mdk 2.1
2850286 LOC227393 2.1
3190685 Ldh1 2.1
4670246 Adam19 2.1
5340093 Mlp 2.1
5820601 Stx3 2.1
2490053 Efna1 2.1
5860010 Spire2 2.1
4210246 Kif22 2.1
3780228 Akr7a5 2.1
1470386 CRG-L1 2.1
6290390 Aurkb 2.1
6250193 Txnip 2.0
610039 E130016E03Rik 2.0
4610722 Cdc20 2.0
4230717 Galk1 2.0
7040544 Lisch7 2.0
3310196 Cdca5 2.0
4480646 Casp6 2.0
650347 MGC68323 2.0
4120008 2610318I01Rik 2.0
6650711 Pfkl 2.0
2370390 Krtcap3 2.0
3450162 Echs1 2.0
3990246 Ahcy 2.0
4540634 2700083E18Rik 2.0
4670598 1700034H14Rik 2.0
4480102 H2afv 2.0
5860358 Vegfa 2.0
3370711 H2afy 2.0
4230142 Rras2 2.0
2510008 Fbxo2 2.0
3520093 Avpi1 2.0
7100008 Mnd1 2.0
2680020 Ocln 2.0
1010131 LOC238943 2.0
4390338 Dgkk 2.0
1470528 Hn1 2.0
3420600 1110060I01Rik 2.0
Table 2
List of the genes downregulated (FC≤−2, FDR=0.05) in XEN cells upon BMP4
treatment.
Illumina ID Gene symbol Fold change
1240424 Nupr1 −23.0
5550161 8430408G22Rik −8.7
2470717 Aqp8 −8.3
2850670 C030002B11Rik −8.1
7160093 Aqp8 −8.0
4590414 Igfbp5 −7.7
2760053 6430704 N06 −7.4
290315 1700093E07Rik −6.9
4010292 Nid1 −6.8
5490121 Capn6 −6.3
5360228 Lor −6.0
430561 Bcat1 −6.0
4920487 Ckb −5.8
4760224 Ctgf −5.7
6550379 1810036H07Rik −5.6
2940592 Gsta1 −5.6
160100 Igfbp5 −5.5
2470040 Gnai1 −5.3
160333 Mllt3 −5.1
1230767 Thbd −5.0
4010082 Ctgf −4.9
160097 Bmper −4.8
6270037 Susd2 −4.6
5080292 Igfbp5 −4.5
870309 Serpine2 −4.5
460403 Gsta1 −4.3
4040435 Ndg2 −4.3
7320685 Akr1b8 −4.3
620372 Sphk1 −4.2
1090239 Pip5k1a −4.2
5420730 Calr3 −4.1
1440019 Cd59a −4.1
6650035 2210401J11Rik −4.1
7040243 D0H4S114 −4.0
70544 Gsta1 −4.0
60593 Tm4sf3 −4.0
2630446 Fbxo15 −4.0
6510270 Sema6d −3.9
3710465 Gsta2 −3.9
1090180 Arhgdib −3.9
1660376 1110032E23Rik −3.8
1340253 4930403J22Rik −3.8
4780164 Krt1-23 −3.8
1300121 9530018I07Rik −3.7
3060019 Fbxo15 −3.7
7040600 Tm7sf1 −3.6
7610239 2510009E07Rik −3.6
380246 5930418K15Rik −3.5
1010435 Gsto1 −3.4
5560112 Ccdc46 −3.4
3440767 9230117N10Rik −3.4
2810685 Glipr1 −3.4
1660368 Vit −3.3
5270452 Tiam1 −3.3
450632 Igf1 −3.3
4120687 Glipr2 −3.2
650435 A730054J21Rik −3.2
3360343 Pde1b −3.2
2350019 Fhl2 −3.2
2230068 Gaa −3.2
4480411 Set7 −3.2
7510072 Gstm2 −3.2
6350196 Mrg1 −3.2
2470228 6330404C01Rik −3.2
7560647 Meis1 −3.1
2070152 Timp2 −3.1
3420056 Pde1b −3.1
510286 Aldh6a1 −3.1
2970500 Serpinb6c −3.1
6200719 Acas2l −3.1
4640685 6230401I02Rik −3.1
4230452 Glipr2 −3.1
3940639 Glipr2 −3.1
(continued on next page)
255J. Artus et al. / Developmental Biology 361 (2012) 245–262the Afp promoter drives very high levels of transgene expression, and
as a result the Afp::GFP reporter is extremely bright, with GFP protein
detectable over 48 h after downregulation of transgene expression
(Kwon et al., 2008), it is likely that the transgene behaves similarly
in our cell culture conditions, and that the loss of GFP ﬂuorescence
takes longer than the 13-hour window for time-lapse image
acquisition.
We next sought to determine if the observed ﬂuctuations in ex-
pression of the Afp::GFP reporter had biological signiﬁcance. Impor-
tantly, for the transgenic reporter to provide a relevant readout for
understanding how XEN cells behave when they respond to BMP
stimulation, it must reﬂect endogenous Afp expression. To address
this question, we analyzed the differences in global gene expression
between GFP-positive and GFP-negative BMP-treated cells (Figs. 6C,
D). As expected, GFP-positive cells exhibited an increase in the level
of Afp expression (Fig. 6D), indicating that the Afp::GFP transgene re-
porter recapitulated endogenous gene activity. Surprisingly, only 5
genes were differentially expressed between GFP-positive and GFP-
negative cells (FC≥2): Afp, Spp2, Lgals1,Wfdc1 and Apom. Interesting-
ly, all of these genes encode secreted proteins. Afp encodes an abun-
dant serum protein speciﬁcally expressed in the VE (Dziadek and
Adamson, 1978; Kwon et al., 2006). Secreted phosphoprotein 2
(also referred as SPP24) acts as a pseudoreceptor that regulates
BMP activity (Brochmann et al., 2009), suggesting a negative feed-
back loop may operate upon BMP stimulation. Spp2 transcripts have
been detected in the yolk sac (Hou et al., 2007), while Galectin-1
Table 2 (continued)
Illumina ID Gene symbol Fold change
4290403 Zfhx1a −3.1
2000722 Calr3 −3.1
610273 Obfc2a −3.1
6130722 Spink4 −3.1
5720136 Aldh3b1 −3.1
7610215 2810410A03Rik −3.0
4280131 Slc24a3 −3.0
3520328 BC038479 −3.0
5890059 Epb4.9 −3.0
1050619 Herpud1 −2.9
3190731 Prickle1 −2.9
4540674 6720469N11Rik −2.9
240348 Chn2 −2.9
7100259 Mme −2.9
6510736 1500005K14Rik −2.9
2120286 Mfge8 −2.9
2690025 Gstm2 −2.9
2230026 9130213B05Rik −2.9
7040253 Msmb −2.9
3930156 Ptpla −2.9
4560731 1110014O20Rik −2.8
50129 Herpud1 −2.8
4540598 Wfdc1 −2.8
3360681 Nppb −2.8
2490682 Dpp7 −2.8
2470754 BQ952480 −2.8
3710544 Mgst3 −2.8
510722 Tgfbr3 −2.8
5960020 Fmnl2 −2.8
4640463 Evl −2.8
4210619 Mgst3 −2.8
7330292 Mgst2 −2.8
5570669 Epb4.9 −2.7
4570201 AA407270 −2.7
4860445 Stard8 −2.7
5670465 Pvrl3 −2.7
6100523 Cugbp2 −2.7
1770152 Itgb5 −2.7
4060075 Nﬁb −2.7
1400601 Stard8 −2.7
3390192 Psca −2.7
6520129 Atf5 −2.7
6380255 Rtn1 −2.6
2000739 1110012J17Rik −2.6
4830040 C130076O07Rik −2.6
70386 Satb1 −2.6
4200678 9030625A11Rik −2.6
60132 LOC385644 −2.6
2850575 Vcam1 −2.6
1690187 Ly6a −2.6
1990091 S100a13 −2.6
7160167 Emp1 −2.6
730025 Gstm2 −2.6
6330195 Camk2n1 −2.6
1440040 Garnl4 −2.6
2370687 Rtn1 −2.6
7610678 Comt −2.6
1300475 Stra6 −2.6
6290133 2310067E08Rik −2.5
3310564 Scarb2 −2.5
4850091 8-Sep −2.5
7320239 Reck −2.5
2000647 Igf1 −2.5
3400050 Man2a1 −2.5
4200341 Lbp −2.5
3420500 Oxct −2.5
3710402 Cln2 −2.5
3830048 Selenbp1 −2.5
4730066 Schip1 −2.5
6620187 Ndrg1 −2.5
1940669 Hexb −2.5
6940136 Mllt4 −2.5
1340255 C330002I19Rik −2.5
6330086 Leprel1 −2.5
6550603 Sepn1 −2.4
5560470 Psap −2.4
1850487 Foxq1 −2.4
Table 2 (continued)
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5900424 LOC384009 −2.4
1300747 Clu −2.4
3890022 Ndrl −2.4
6480554 BC023892 −2.4
2360519 Tek −2.4
1070274 St3gal4 −2.4
5340091 2310058A03Rik −2.4
3450180 1810009M01Rik −2.4
7160070 6430548M08Rik −2.4
1660450 Tmtc4 −2.4
1050095 Upp1 −2.4
650291 Calr −2.4
4880026 Tspan17 −2.4
4920193 Mertk −2.4
6280689 9530081N05Rik −2.4
6940634 Mllt3 −2.4
2140753 Grina −2.4
6040292 Tgfb1i4 −2.4
4050670 Efnb2 −2.4
1850170 Slc6a15 −2.3
5700364 Trpm6 −2.3
4670504 LOC382162 −2.3
2140678 Tmem150 −2.3
580465 Klf3 −2.3
3400577 Mybpc3 −2.3
3390221 Bace2 −2.3
4900110 Lamc1 −2.3
6270112 Frrs1 −2.3
5050427 Lamc1 −2.3
2680520 mtDNA_ND4L −2.3
2760139 A830039N02Rik −2.3
2350397 Wars −2.3
1190431 Lama1 −2.3
5820204 Emp2 −2.3
1580349 1810006K23Rik −2.3
7050328 2310016C16Rik −2.3
110706 Ppic −2.3
3610440 Psap −2.3
6200563 Cct6b −2.3
3870328 2310016C16Rik −2.3
150504 Efna5 −2.3
6960369 Aadacl1 −2.3
6550082 Lamb1-1 −2.3
270681 E030026I10Rik −2.3
2190048 2310005P05Rik −2.3
5960070 Fkbp9 −2.3
4480333 Ppic −2.2
3460110 5031436O03Rik −2.2
6510465 Mfge8 −2.2
5390193 Cd59b −2.2
430403 Ppﬁbp2 −2.2
5670634 Synpo −2.2
1110382 Arl10b −2.2
5860725 6430527G18Rik −2.2
2680561 Ctns −2.2
7050546 Hist2h2aa1 −2.2
2810603 AW536289 −2.2
1850037 Knsl5 −2.2
510050 Sparc −2.2
1990674 Clps −2.2
870370 A930001D11Rik −2.2
7160307 Nr2f1 −2.2
3780040 Taf9b −2.2
5260079 Fchsd2 −2.2
6620717 Pdir −2.2
6020609 Sesn1 −2.2
6020356 Prickle1 −2.2
5820133 Ampd2 −2.2
1240259 Comt −2.2
6520603 Reck −2.2
6510112 Ybx3 −2.2
4640114 Actb −2.2
3400709 scl0001905.1_3 −2.2
7050477 Spock1 −2.2
2100402 Bgn −2.2
2900333 Pdir −2.2
7050056 Crtap −2.2
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Illumina ID Gene symbol Fold change
2510382 3732412D22Rik −2.2
620593 Crtap −2.2
1230612 Aqp1 −2.2
1410113 Uap1l1 −2.2
6940278 Bmp1 −2.2
4230086 Slc39a13 −2.2
3120520 mtDNA_ND5 −2.2
7650154 C130027E04Rik −2.2
2600286 Fgf10 −2.2
6270131 2310009N05Rik −2.2
1190377 Cerk −2.2
6650039 Raver2 −2.2
4180437 Slc7a5 −2.2
2100278 Plk2 −2.2
50242 9430080K19Rik −2.2
20706 5730537D05Rik −2.1
5860075 App −2.1
3460670 Oxct1 −2.1
4780113 Large −2.1
1850041 5-Sep −2.1
4210139 Aqp1 −2.1
7200520 Ostm1 −2.1
2470746 A830080H07Rik −2.1
2070376 Xpnpep2 −2.1
3400546 Slc12a2 −2.1
2600121 Pigt −2.1
3930050 2310016C16Rik −2.1
5340446 6330439P19Rik −2.1
7400392 Sepw1 −2.1
2480059 Anxa5 −2.1
7050446 Cklfsf3 −2.1
2000373 Serping1 −2.1
6350132 Ctsl −2.1
4730634 4631422O05Rik −2.1
5360551 B430214A04Rik −2.1
5420397 Tbc1d2b −2.1
50079 Hist1h1c −2.1
4860630 9930116P15Rik −2.1
4880553 Sox5 −2.1
5810398 Rnase4 −2.1
5090445 Unc84b −2.1
3850113 A730017D01Rik −2.1
1300082 Clcn2 −2.1
2260253 Clps −2.1
160292 Tyro3 −2.1
4040181 Hey2 −2.1
5090619 4732435N03Rik −2.1
3930154 Tmem150 −2.1
1170037 Sdfr2 −2.1
1820224 Marcks −2.1
1440600 Copz2 −2.1
2630224 Gnaq −2.1
6400669 Aldh3b1 −2.1
1260519 5033403D15Rik −2.1
1230411 Xpot −2.0
3450735 Wars −2.0
6550523 9630037P07Rik −2.0
840541 Ptk6 −2.0
270086 Slc5a5 −2.0
4150739 Cdc42ep3 −2.0
4200059 Selenbp2 −2.0
7380048 BC017612 −2.0
130519 Sat1 −2.0
7380241 C230093N12Rik −2.0
2320356 Calu −2.0
5490452 Galnt2 −2.0
130121 Asah1 −2.0
5870687 Slc29a1 −2.0
7650273 Hist1h1c −2.0
50292 Cobl −2.0
4280064 Rcn3 −2.0
5080594 Mtap −2.0
830608 Trpm6 −2.0
60639 Sbk −2.0
4260181 4930506M07Rik −2.0
5570132 Ppm1l −2.0
6560181 Lepre1 −2.0
(continued on next page)
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4060132 Lrp4 −2.0
1470553 Cpxm1 −2.0
257J. Artus et al. / Developmental Biology 361 (2012) 245–262(LGALS1) is a β-galactoside binding lectin protein that regulates MAPK
signaling in various cellular contexts (Brandt et al., 2010; Thijssen et al.,
2010). The expression of LGALS1 has not been reported in vivo in the ex-
traembryonic endoderm, but it was previously reported to be activated
after retinoic acid induced endodermal differentiation of F9 embryonal
carcinoma cells (Lu et al., 1998). WAP four-disulﬁde core domain 1
(WFDC1, also referred as PS20) was identiﬁed as a prostate secreted
protein with a putative serine protease inhibitor activity. WFDC1 in-
hibits proliferation and induces the synthesis of secreted proteins
(Madar et al., 2009; Rowley et al., 1995). Lastly, Apom encodes a HDL-
associated apolipoprotein who's expression is regulated by insulin
through FOXA2 in adult animals (Wolfrum et al., 2008). Given the
small number of genes exhibiting ﬂuctuating expression, it is tempting
to speculate that common mechanisms may regulate their expression.
The observed dynamic equilibrium of Afp::GFP expressing vs. non-
expressing cells in BMP4-treated XEN populations resembled obser-
vations made in various pluripotent cell types. This is the case of
mouse ES cells which exhibit heterogenous expression of several
markers including Nanog (Chambers et al., 2007; Singh et al., 2007),
Rex1 (Toyooka et al., 2008) and Stella (Hayashi et al., 2008). Several
subpopulations have also been described in EpiSCs (Han et al.,
2010) and in human ES cells (Enver et al., 2005; Fischer et al., 2010;
Hough et al., 2009; Stewart et al., 2006). The current model posits
that pluripotency is associated with various (or a spectrum of) usually
interconvertible metastable states, each of which is deﬁned by the ex-
pression of distinct markers, as well as different abilities to differenti-
ate. A similar situation may occur during PrE lineage maturation, and
therefore may be the case in BMP4-treated, as well as untreated XEN
cells. Indeed, untreated XEN cells undergo morphological transitions
that are likely to be associated with ﬂuctuations in gene expressing
revealing an inherent bistability in the system (Kunath et al., 2005).
Additional studies will be required to address the origin and signiﬁ-
cance of the ﬂuctuations that are observed and stably maintained in
XEN cells.Investigating the developmental potential of BMP-treated XEN cells
To conﬁrm the exVE-like identity of BMP-treated XEN cells, we
sought to assess their developmental potential. First, when XEN
cells were injected under the kidney capsule of an adult mouse,
they generated teratomas, as do ES cells. We observed that after
2 months, grafts of BMP-treated XEN cells usually developed into vis-
ible teratomas, but at different rates (Fig. S5A), likely resulting from
variations in the number of grafted cells. Histological sections of
these XEN cell-derived teratomas revealed they comprised a limited
number of cell types, usually only two, as distinguished by their eo-
sinophilic coloration (Fig. S5C′ and C″ are high magniﬁcation of the
two cell types). Overall, cells were organized into small clusters and
were surrounded by extensive deposits of extracellular matrix, as vi-
sualized by the green coloration (Fig. S5B–C). The identity of these
cells was not determined, but these data suggest that BMP-treated
XEN cells, like untreated XEN cells (data not shown), exhibit a re-
stricted developmental potential. In contrast, in teratomas formed
from grafts of ES (and iPS) cells, the cells differentiate into multiple
cell types comprising derivatives of all three germ layers. Since we
noted that BMP treatment was reversible (Fig. 2), and since BMP sig-
naling likely would not be sustained in the XEN cell kidney capsule
grafts, we did not pursue this line of investigation any further.
258 J. Artus et al. / Developmental Biology 361 (2012) 245–262We therefore sought to determine the developmental potential of
BMP-treated XEN cells by generating chimeras. To do this, we
injected 5–10 BMP-treated XEN cells into recipient E3.5 blastocysts,
transferred them to pseudopregnant females, recovered embryos atF
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Fig. 7. XEN cells promote EryP progenitor expansion. (A) Schematic representation of the assay used to test XEN cell ability to promote EryP expansion. (B) A representative red EryP col-
ony expressing the ε-globin::H2B-GFP transgene (GFP). Brigthﬁeld, bf. Scale bar: 50 μm. (C) The diagramdepicts the average fold change in EryP colonynumber for EryP co-coculturedwith
XEN cells and BMP4-treated XEN cells compared to culture of EryP alone (n=6 experiments). P-values calculated from Mann–Whitney test indicate statistical signiﬁcance.
259J. Artus et al. / Developmental Biology 361 (2012) 245–262This observation is in agreement with other reports in which 99% of
wild-type XEN cells preferentially contributed to the PE layer in chi-
meras (Kruithof-de Julio et al., 2011; Kunath et al., 2005). A possible
reason for this failure to promote XEN cell contribution to the VE
cell layer is that injected XEN cells (BMP-treated or not) preferential-
ly interact with the TE layer of the blastocyst. Support for this comes
from our observation that the majority of XEN cells attached to the
mural TE in injected E3.5 blastocysts cultured for 24 h (data not
shown). Alternatively, BMP-treated XEN cells may fail to sustain
BMP signaling following their injection and may, therefore, revert to
their original state, behaving as untreated XEN cells. To deﬁnitively
assess the developmental potential of BMP-treated XEN cells in
these assays, it would be necessary to maintain BMP signaling in a
cell autonomous manner in embryo chimeras.
XEN cells stimulate the expansion of EryP progenitors in vitro
We previously reported that development of the primitive ery-
throid and vascular endothelial lineages is regulated by a signal(s) se-
creted from the adjacent exVE (Belaoussoff et al., 1998; Dyer et al.,Fig. 6. Fluctuation of Afp::GFP reporter within the BMP-treated XEN cell population. (A) Det
GFP-positive cells determined by ﬂow cytometry upon culture for 4 days in the presence of
gramatic representation of the experimental scheme used for global gene expression proﬁl
differentially upregulated (green, FC≥2) and downregulated (red, FC≤−2) in the GFP-po
GFP-negative cells (upper panels) and the GFP-positive cells (lower panels). The diagram
FACS sorted cells. (F) Single frames from 3D time-lapse imaging of Afp::GFPTg/+ XEN cells t
cells upregulating GFP during the time-course are highlighted (red dashed lines depict cell
bf. Scale bars: 50 μm.2001). To evaluate the VE-like properties of control and BMP-
treated XEN cells, we tested whether these cells could promote the
expansion of EryP progenitors in a co-culture assay. To do this, we
took advantage of a transgenic mouse line carrying an ε-globin::
H2B-GFP transgene speciﬁcally expressed in primitive erythroid cells
that we previously generated and validated (Isern et al., 2008, 2010,
2011). Importantly, we demonstrated that all EryP progenitor activity
is present within the GFP-positive population of cells from ~E7.5 to
E8.5 embryos and that this activity is lost by E9.5 (Isern et al.,
2011). GFP-positive EryPs were FACS-sorted from E8.0 to E8.5 trans-
genic embryos and cultured alone or in the presence of untreated or
BMP4-treated XEN cells for 5 (data not shown) or 10 h. The non-
adherent EryP were then collected and cultured at clonal density in
EryP-colony-forming cell (CFC) assays for 4–5 days (Fig. 7A). Red col-
onies that developed contained GFP-positive cells conﬁrming their
EryP identity (Fig. 7B). The number of EryP progenitors was stimulat-
ed by 2.2-fold in co-cultures with control XEN cells, and by 3.2-fold in
co-cultures with BMP4-treated XEN cells (Fig. 7C). Therefore, both
untreated and BMP4-treated XEN cells stimulated the numbers of
EryP progenitors, suggesting that these cells regulate primitiveection of the Afp::GFP transgene in control and BMP4-treated XEN cells. (B) percentage
various concentrations of BMP2 or BMP4 in serum and serum-free conditions. (C) Dia-
ing in GFP+ and GFP-XEN cells maintained in 10 ng/mL BMP4. (D) The 5 genes found
sitive population. (E) Kinetics of Afp::GFP reporter expression after FACS sorting of the
s depict the evolution of the percentage of GFP-positive cells in the GFP- and GFP+
reated with 10 ng/mL BMP4. Annotated movie sequence is provided as Movie 1. Some
perimeters). (A, E, F) GFP, green; nuclei counterstained with Hoechst, blue, brightﬁeld,
260 J. Artus et al. / Developmental Biology 361 (2012) 245–262hematopoiesis. However, our data also suggest that the enhancement
of EryP progenitor expansion by BMP4-treated XEN cells might be
more potent than that of untreated cells, which would correlate
with the acquisition of an exVE-like identity.
Interestingly, we noted that Vegfa and Ihh genes were upregulated
in BMP-treated XEN cells by 2.0- and 1.9-fold respectively. Vegf
(Miquerol et al., 1999) and Ihh (Dyer et al., 2001) are both expressed
by the VE of mouse embryos. Gene targeting studies have established
a requirement for VEGF in primitive erythropoiesis (Carmeliet et al.,
1996; Ferrara et al., 1996) that is mediated, at least in part, through
Gata1 (Drogat et al., 2010). IHH protein can substitute for VE in em-
bryo explant cultures and may function through activation of Bmp4
(Dyer et al., 2001). It is likely that the enhanced ability of BMP4-
treated XEN cells to promote EryP expansion is partly due to the upre-
gulation of these genes; however we cannot exclude additional as yet
unknown contributing factors.
Conclusions
By investigating the mechanisms promoting XEN cell differentia-
tion we have determined that BMP signaling directs XEN cells to-
wards an exVE identity. In doing so, BMP induces stable but
reversible, cell polarization and epithelialization, and upregulation
of genes highly expressed within the exVE, as well as the expression
of a ﬂuorescent VE-speciﬁc live imaging reporter. Validating their
exVE identity, our data suggest that BMP-treated XEN cells promoted
hematopoiesis by enhancing the proliferation of EryP progenitors.
Notably the effect of BMP treatment on XEN cells was antagonized
by LIF signaling, suggesting that reciprocal signaling pathways control
the balance between PrE cell states.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.10.015.
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